Table 2.
The MLR model for risk factors of bacterial co-infection in hospitalized COVID-19 patients
| Exp(B) | 95.0% CI | p value | ||
|---|---|---|---|---|
| Age (years) | 1.003 | 0.991 | 1.015 | 0.634 |
| Chronic lung diseases | 1.202 | 0.748 | 1.932 | 0.447 |
| Cardiovascular disease | 1.847 | 1.202 | 2.837 | 0.005 |
| Disease severity for COVID-19*: | 0.030 | |||
| Non-COVID-19 (referent) | ||||
| Severe COVID-19 | 1.694 | 1.033 | 2.778 | 0.037 |
| Critical COVID-19 | 2.220 | 1.196 | 4.121 | 0.012 |
| WBC (109/L) | 0.995 | 0.949 | 1.044 | 0.851 |
| PCT (ng/mL) | 1.016 | 0.934 | 1.104 | 0.717 |
| CRP (mg/L) | 1.001 | 0.998 | 1.005 | 0.548 |
| IL-6 (μg/L) | 1.000 | 0.999 | 1.002 | 0.668 |
| D-Dimer (mg/L) | 0.996 | 0.957 | 1.037 | 0.849 |
| LDH | 1.000 | 0.998 | 1.001 | 0.805 |
Disease severity for COVID-19*, take non-severe COVID-19 as a reference; MLR, multivariable logistic regression; WBC, white blood cell; PCT, procalcitonin; CRP, C-reactive protein; IL-6, interleukin 6; LDH, lactic dehydrogenase